INMB (STOCKS)
INmune Bio Inc. Common stock
$1.520400
-0.079600 (-4.98%)
Prev close: $1.600000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- David J. Moss
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $44.51M
- Employees
- 13
- P/E (TTM)
- -0.73
- P/B (TTM)
- 1.68
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $50.00K |
| Benefits Costs and Expenses | -$42.07M |
| Costs And Expenses | -$33.29M |
| Nonoperating Income/Loss | $1.49M |
| Operating Expenses | $51.43M |
| Research and Development | $25.68M |
| Other Operating Expenses | $25.74M |
| Operating Income/Loss | -$51.38M |
| Income/Loss From Continuing Operations After Tax | $34.28M |
| Income/Loss From Continuing Operations Before Tax | $35.65M |
| Net Income/Loss | -$49.89M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$49.89M |
| Net Income/Loss Available To Common Stockholders, Basic | -$49.89M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.08 |
| Diluted Earnings Per Share | -$2.08 |
| Basic Average Shares | 24,909,064 |
| Diluted Average Shares | 24,909,064 |
| Assets | $33.36M |
| Current Assets | $30.67M |
| Prepaid Expenses | $132.00M |
| Noncurrent Assets | $2.69M |
| Fixed Assets | $878.00K |
| Other Non-current Assets | $1.81M |
| Liabilities | $7.98M |
| Current Liabilities | $7.36M |
| Noncurrent Liabilities | $623.00K |
| Equity | $25.38M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $25.38M |
| Liabilities And Equity | $33.36M |
| Net Cash Flow From Operating Activities | -$30.65M |
| Net Cash Flow From Operating Activities, Continuing | -$30.65M |
| Net Cash Flow From Investing Activities | $11.73M |
| Net Cash Flow From Investing Activities, Continuing | $12.19M |
| Net Cash Flow From Financing Activities | $25.47M |
| Net Cash Flow From Financing Activities, Continuing | $25.47M |
| Exchange Gains/Losses | $265.00K |
| Net Cash Flow | $6.35M |
| Net Cash Flow, Continuing | $6.09M |
| Comprehensive Income/Loss | -$49.62M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$49.62M |
| Other Comprehensive Income/Loss | -$49.62M |